Pharmacology Ibalizumab was approved by FDA in 2018 April for ( REPEAT) A HIV B TB C Leprosy D Malaria 💡 Explanation Ibalizumab was approved by FDA in 2018 April for ( REPEAT) ✓ Correct Answer: A. HIV